Melanoma Effectiveness of Vemurafenib on BRAF V600 Mutations

被引：0
|
作者：
Voos, Dunja
机构：
来源：
AKTUELLE DERMATOLOGIE | 2014年 / 40卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：434 / 434
页数：1
相关论文
共 50 条
  • [1] Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations
    Hyman, David M.
    Puzanov, Igor
    Subbiah, Vivek
    Faris, Jason E.
    Chau, Ian
    Blay, Jean-Yves
    Wolf, Juergen
    Raje, Noopur S.
    Diamond, Eli L.
    Hollebecque, Antoine
    Gervais, Radj
    Elena Elez-Fernandez, Maria
    Italiano, Antoine
    Hofheinz, Ralf-Dieter
    Hidalgo, Manuel
    Chan, Emily
    Schuler, Martin
    Lasserre, Susan Frances
    Makrutzki, Martina
    Sirzen, Florin
    Veronese, Maria Luisa
    Tabernero, Josep
    Baselga, Jose
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (08): : 726 - 736
  • [2] Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations
    Flaherty, Keith T.
    Infante, Jeffery R.
    Daud, Adil
    Gonzalez, Rene
    Kefford, Richard F.
    Sosman, Jeffrey
    Hamid, Omid
    Schuchter, Lynn
    Cebon, Jonathan
    Ibrahim, Nageatte
    Kudchadkar, Ragini
    Burris, Howard A., III
    Falchook, Gerald
    Algazi, Alain
    Lewis, Karl
    Long, Georgina V.
    Puzanov, Igor
    Lebowitz, Peter
    Singh, Ajay
    Little, Shonda
    Sun, Peng
    Allred, Alicia
    Ouellet, Daniele
    Kim, Kevin B.
    Patel, Kiran
    Weber, Jeffrey
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (18): : 1694 - 1703
  • [3] BRAF V600 mutations and pathological features in Japanese melanoma
    Yamazaki, N.
    Tanaka, R.
    Tsutsumida, A.
    Namikawa, K.
    Eguchi, H.
    Omata, W.
    Oashi, K.
    Tsuta, K.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S874 - S874
  • [4] VEMURAFENIB FOR BRAF V600 MUTATED ADVANCED MELANOMA: RESULTS OF TREATMENT BEYOND PROGRESSION
    Haanen, J. B. A. G.
    Scholtens, A.
    Geukes, M.
    van Thienen, H.
    van Tinteren, H.
    [J]. ANNALS OF ONCOLOGY, 2014, 25
  • [5] Safety of vemurafenib in patients with BRAF V600 mutated metastatic melanoma: the Spanish experience
    Arance, A. M.
    Berrocal, A.
    Lopez-Martin, J. A.
    de la Cruz-Merino, L.
    Soriano, V.
    Martin Algarra, S.
    Alonso, L.
    Cerezuela, P.
    La Orden, B.
    Espinosa, E.
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2016, 18 (11): : 1147 - 1157
  • [6] Vemurafenib for BRAF V600 mutated advanced melanoma: Results of treatment beyond progression
    Scholtens, A.
    Foppen, M. H. Geukes
    Blank, C. U.
    van Thienen, J. V.
    van Tinteren, H.
    Haanen, J. B.
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 (05) : 642 - 652
  • [7] BRAF V600 mutations and pathological features in Japanese melanoma patients
    Yamazaki, Naoya
    Tanaka, Ryota
    Tsutsumida, Arata
    Namikawa, Kenjiro
    Eguchi, Hironobu
    Omata, Wataru
    Oashi, Kohei
    Ogawa, Toru
    Hayashi, Amiko
    Nakamura, Noriyuki
    Tsuta, Koji
    [J]. MELANOMA RESEARCH, 2015, 25 (01) : 9 - 14
  • [8] Vemurafenib in Patients Harboring V600 and Non V600 BRAF Mutations: Final Results of the NSCLC Cohort from the AcSe Trial
    Mazieres, J.
    Montane, L.
    Barlesi, F.
    Coudert, B.
    Souquet, P. J.
    Otto, J.
    Gervais, R.
    Moro-Sibilot, D.
    Monnet, I.
    Brain, E.
    Huillard, O.
    Quere, G.
    Debieuvre, D.
    Fabre, E.
    Jaffro, M.
    Collot, S.
    Ferretti, G.
    Tiffon, C.
    Oukhatar, C. Mahier-Ait
    Blay, J.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S348 - S349
  • [9] THE COST OF STAGE IV MELANOMA WITH BRAF V600 MUTATIONS IN GREECE
    Carayanni, V
    Gogas, H.
    Bafaloukos, D.
    Boukovinas, I
    Latsou, D.
    Stamuli, E.
    Hatzikou, M.
    [J]. VALUE IN HEALTH, 2020, 23 : S462 - S462
  • [10] BRAF V600 Mutation in Malignant Melanoma
    Czirbesz, K.
    Plotar, V
    Serester, O.
    Liszkay, G.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 : 44 - 45
12345